ArticlePloS one2021

An inhibitor of programmed death ligand 1 enhances natural killer cell-mediated immunity against malignant melanoma cells.

Young Shin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.